×

3D Predict Unveils Innovative AI-Driven Teeth Aligners in US

Posted on September 25, 2020

3D Predict™, the international software developer and manufacturer of innovative dental aligners based on Artificial Intelligence (AI) technology, is launching in the US with a new headquarters in New York. The medical technology company has gained global recognition for its one-of-a-kind AI software, that produces highly precise 3D models of the smile including the crowns, bone and roots. These models are used to design dental aligners. 3D Predict aligners prevent tooth movements that are anatomically impossible resulting in 50% fewer teeth alignment corrections and a 30% reduction in treatment time. 3D Predict received FDA clearance in February.

“As a result of today’s COVID restrictions, currently more and more doctors are making their choice in favor of clear aligner therapy versus braces. Treatment using clear aligners requires less frequent and shorter consultations with less manual procedures, so it is safer and more convenient for doctors and patients in the current environment,” said Marina Domracheva, M.D., Founder and CEO of 3D Predict.

Orthodontics is nearly a $2 billion market in the US today, with five million patients starting orthodontic treatment every year. Approximately four million of those are complex and moderate cases. Unlike other aligners and braces, 3D Predict uses root and bone analysis for greater predictability to treatment. 3D Predict provides information to orthodontists about potential treatment obstacles, such as root collision, shows how roots will move during treatment which allows doctors to formulate a more predictable and safe treatment plan.

“The growing orthodontics market is driving an even greater demand for more effective treatment models,” added Domracheva. “We saw a way to combine clinical experience and cutting-edge technology to equip orthodontists with a dental device to treat even the most complex cases with greater precision and efficiency.”

3D Predict Aligners are designed on Artificial Intelligence (AI) technology which boosts effectiveness, reduces the number of corrections by half and associated chair time by 30%. This allows doctors to increase their margin and save time for new patients.

“The application of technology in aligners equips doctors with a depth of information about the tooth that was previously not available,” says Dr. Maria Sokolina, DDS, who practices in NY and NJ, “3D Predict gives us meticulous detail using data that allows doctors to analyze the tooth as a whole yielding better outcomes for the patient.”

3D Predict’s™ proprietary software fuses data on patients' crowns, real roots and bone. The orthodontist is able to analyze the tooth as a whole, make a more effective treatment plan preventing at least five extra patient visits due to reduction in corrections.

To learn more about 3D Predict, visit www.3dpredict.com.

About 3D Predict

Founded in 2014 by Dr. Marina Domracheva, 3D Predict’s patented and proprietary AI software produces highly precise 3D models of the smile including the crowns, bone and roots. 3D Predict dental aligners enable orthodontists to treat patients faster, safer and more effectively.







The 2020 Greater New York Dental Meeting is Going Virtual

Posted on September 25, 2020

Join us November 27th to December 2nd

For 96 years, the Greater New York Dental Meeting, as the largest Dental event in the United States, has been honored to collaborate with the entire Dental team and the Dental Trade. Responsible New York State officials have now decided that the Greater New York Dental Meeting cannot hold a face-to-face event that has grown to 55,000+ attendees and so we will be transitioning to a free virtual meeting.

Even with the current pandemic challenges, we decided to change the conversation to a celebration of our profession and the future and we will be bringing you great speakers, innovative programming, and a wide variety of exhibitors at this free virtual event.

Please consider attending this special virtual meeting and upgrade your practice skills and knowledge, plus demonstrate support for our commercial exhibitors, who will be running Meeting Specials on their products and services.

Our event this year will reduce attendee’s costs to zero:

· FREE Registration

· FREE CERP approved Continuing Education Programs

· FREE Visits to the Exhibit Floor

· FREE Access to "Live" Dentistry Program recordings

· FREE Access Specialty Programming

· FREE Access to Our 3D/Digital/Technology Pavilion

· FREE Access to Our New Products Pavilion

Unfortunately, the registration requirements for this new venue have changed, so even though you already preregistered for our traditional event, you will have to preregister again. Virtual registration will be coming soon. Our CERP approved educational program will be published by November 1st.

Subscribe to GNYDM email notifications and follow us on Facebook and Instagram for the latest regarding our virtual conference. Thank you for your continued support, and we look forward to seeing you online in November.



Sincerely,

Lois A. Jackson, D.D.S.

President-Elect

New York County Dental Society

Paul A. Albicocco, D.M.D.

President

Second District Dental Society

James H. Doundoulakis, D.M.D.

General Chairman

Greater New York Dental Meeting







Ditron Dental USA Announces Launch of Commercial Operations in US

Posted on September 24, 2020

Ditron Dental USA, the US affiliate of Ditron Dental, a subsidiary of Ditron Precision Ltd., will officially commence commercial operations for its dental implant portfolio as of October 1st, 2020. Ditron Dental USA is able to capitalize on over 50 years of experience by the corporate parent in the manufacture of ultra-precise components for the aerospace, automotive, and medical device Industries. The company applied its multi-disciplinary philosophy teaming engineers, micro-machining operators, and top-notch clinicians to develop its dental implant portfolio, resulting in products with an astounding sub-micron level of accuracy. The product portfolio is represented by the flagship ULT™ Ultimate Precision Dental Implant System and the MPI™ Molecular Precision Implant System, both featuring a host of design innovations in addition to the ultra-precise manufacturing.

"Our goal is to launch something exceptional in terms of the product line and business approach into what is an already crowded US dental implant market,”, said Ole Jensen, OMS founder of Ditron Dental USA and Chairman of the Board. “In addition to what I believe to be the most precise dental implants in the world, we have assembled one of the most prestigious clinical advisory boards to help guide and support our path to growth. As a forward-looking organization, we have already made substantive investments in antimicrobial technologies that will further differentiate our implant offering in the years to come,” added Dr. Jensen.

“Commercially, we are building out a national team of seasoned dental implant industry professionals to complement our world-class advisory board”, stated Mike Stevens, Chief Executive Officer of Ditron Dental USA. As Mr. Stevens continued, “while the innovations and precision manufacturing are critical to our success, it is the Ditron team members and clinical advisors who will personify and bring to life what we have to offer by introducing clinicians and their patients to the Ditron experience. I am pleased to have Brian Bashaw, a 30-year dental implant industry veteran and prior executive with some of the market leaders, to be joining Ditron Dental USA to lead our commercial efforts as Chief Commercial Officer.”

The company’s commercialization efforts are being supported by Cellerant Consulting, a dental incubator and highly specialized consulting firm that focuses exclusively on the dental industry. Cellerant’s CEO, Dr. Lou Shuman, added “we are pleased to be working with Ditron on their US launch. Dr. Jensen is such a respected and accomplished Oral & Maxillofacial surgeon, so his involvement instills confidence. Add to that a very solid product portfolio, a best-in-class group of clinical advisors, and a growing team of industry experts and this company is sure to achieve a high level of success.”

To remain apprised of new developments with Ditron Dental USA and to take advantage of special offers, please register at https://ditrondentalusa.com/register/

About Ditron Dental USA: Ditron Dental USA offers a comprehensive portfolio of dental implants and related prosthetic components with a focus on innovation and ultra-precise manufacturing. The dental implant portfolio includes the ULT™ Ultimate Precision, MPI™ Molecular Precision, and OPI™ One-Piece Dental Implant Systems. Established in 2020 and headquartered in Ladera Ranch, CA, Ditron Dental USA is the US affiliate of Ditron Dental, a subsidiary of Ditron Precision LTD which was founded in 1968 and is located in Ashkelon, Israel. The Ditron culture embodies a relentless focus on precision, quality, and reliability as manifest in its customer relationships across the automotive, aerospace, and medical device segments. Ditron Dental USA aims to complement an exceptional product portfolio with world-class educators, experienced representatives, and a sensible pricing policy to create lasting customer relationships. For more information visit ditrondentalusa.com.

 







CS 3700 Ranked First in Trueness in Latest In-Vitro Study

Posted on September 23, 2020

Scientific literature has shown intraoral scanners to be highly successful in creating digital impressions for designing short-span restorations and partial prosthesis; however, scanning fully edentulous arches is less studied. Now, a new comprehensive in-vitro study testing the trueness of 12 intraoral scanners when scanning full-arch implant impressions has found the CS 3700 intraoral scanner to offer the truest results when capturing scan bodies in an edentulous arch, giving doctors more confidence that they’re getting the best results when creating digital impressions with the CS 3700.

The study compared the trueness—or how closely the digital scans matched the actual object—of 12 intraoral scanners when scanning a stone model of an edentulous arch with scan bodies. Two methods were used to assess trueness. Method 1 directly evaluated the quality/accuracy of the scan of each intraoral scanner. Method 2 evaluated the resulting accuracy of each intraoral scanner in early stages of prosthetic CAD modeling.

Carestream Dental’s newest scanner, the CS 3700, was shown to have the best trueness, with a mean error 30.4 mm, when tested by Method 1. The study found the performance differences between the scanners tested to be statistically significant, with CS 3700 outperforming all the other 11 scanners.

“Being able to confidently scan a full edentulous arch is every scanner manufacturer’s goal,” Ed Shellard, D.M.D., chief dental officer, Carestream Dental, said. “The CS 3700 features advanced acquisition software—CS ScanFlow—that ensures the accuracy of the dataset while making it 20 percent faster than the Carestream Dental CS 3600 intraoral scanner.”

Taking into consideration the results of both methods, the study ranked the CS 3700’s performance among the intraoral scanners with the highest accuracy, defined as having a mean error of <40 mm with Method 1 analysis and <25mm with Method 2 analysis. Carestream Dental’s CS 3600 intraoral scanner was also included in the study and was also listed among the scanners with the highest accuracy.

Both scanners are capable of high-speed scanning and include smart features like guide arrows that show users the ideal direction to scan. Users can choose from orthodontic, restorative and implant-borne restorative workflows. They can also capture different bite registrations for fabricating sleep devices.

To learn more about the CS 3700, the CS 3600 or any of Carestream Dental’s innovative solutions, visit carestreamdental.com.

  







Owandy Radiology Expands its Commitment to North American Dental Market by Relocating to Larger U.S. Headquarters

Posted on September 23, 2020

Owandy Radiology Inc., a global leader in the manufacture of dental radiology hardware and imaging software, recently moved its US headquarters to 55 Lumber Road Roslyn, New York to better serve the North American dental market.

The company, which has maintained a presence in the United States for more than 15 years, experienced exponential growth prior to COVID-19 and expects to resume its upward trajectory in Q4 2020 and beyond. “Fortunately, Owandy was able to build a very robust sales pipeline prior to the pandemic,” explains Boris Loyez, Owandy’s VP of Sales, and marketing for North America. “We are continuing many of our sales discussions where we left off and have been able to finalize many transactions.”

Owandy’s recent sales growth has been fueled by several innovative new products launched last year - especially the I-Max 3D cone beam unit, which was well received during demonstrations during an aggressive 2019 dental meeting schedule.

“The recent move enables Owandy to hire the additional employees required to respond quickly and efficiently to the demands of its North American customers. “Our new hires will not only include field sales representatives, but also administrative and accounting personnel, as well as well trained technicians and engineers,” says Loyez. The custom-configured facility will also be able to host hands-on technical training for distributors and customers.

Owandy Radiology is now one of the key players in the dental radiology market. Its innovative "wall-mounted" concept makes its brand new I-Max 3D cone beam the most compact unit on the market, featuring excellent image quality and a 12x10 cm FOV. Installation is completed in record time by a single technician. In addition, Owandy Radiology has a complete range of imaging products, including intraoral X-rays, intraoral sensors, digital cameras, 2D pan-ceph and CBCTs.

About Owandy Radiology, Inc.:

Headquartered in France, and serving North America from Roslyn, New York, Owandy Radiology is a global leader in the manufacture of dental radiology hardware and imaging software designed for the most demanding dental professionals. Its products are distributed through dental dealers across the USA, and in 70 countries world-wide, on every continent. For more information, visit www.owandy.com or contact us at sales@owandyus.com. DSO, dealer, and distributor inquiries welcome. 







Dental Wings Wins Prestigious Red Dot Award for Excellent Interface Design

Posted on September 23, 2020

Dental Wings is proud to announce that its coDiagnostiX® EASY Mode is among this year’s winners of the coveted Red Dot design awards. coDiagnostiX is a software for dental professionals to plan dental implant placement and design surgical guides which will then guide the instruments during surgery to achieve predictable results. The coDiagnostiX team succeeded in winning over the Red Dot jury with the outstanding design quality of the new coDiagnostiX EASY Mode.

“With the EASY Mode, we are offering a second user interface of coDiagnostiX software tailored towards coDiagnostiX beginners. The EASY Mode is intuitive, streamlined and has been reduced to the essential functions,” explains Frank Stockmann, VP Guided Surgery at Dental Wings and coDiagnostiX co-founder.

“This helps dental professionals who are new to coDiagnostiX to quickly learn the use of the software on their own and start planning standard cases.” It complements our tried and tested EXPERT Mode with enhanced functionality for more advanced users to support even complex cases.

coDiagnostiX software has been on the market for more than 20 years now and is being developed in the Dental Wings subsidiary in Chemnitz, Germany.

The Red Dot is an international design prize awarded to applicants who stand out with their creativity and the high design quality of their product. The coDiagnostiX team is proud to be amongst the winners of one of the most prestigious design prizes worldwide. In 2020, the international jury assessed a total of 6,992 creative projects and brands from more than 50 countries.







FDI World Dental Federation and Smile Train

Posted on September 23, 2020

 Cleft lip and palate (clefts) are the most common birth difference of the face and mouth and impact the development of the mouth, gums, and palate.

- Regular and focused dental care should be integrated into cleft care to help address oral hygiene challenges and prevent oral disease.

- FDI World Dental Federation (FDI) and Smile Train are releasing new Oral Health in Comprehensive Cleft Care guidelines to empower local cleft teams with training andresources to improve oral health

Around the world, a baby is born with a cleft about every three minutes. Many children with clefts have severe difficulties eating, breathing, hearing, and speaking. What's more, even after having cleft surgery, these children often have a higher risk for tooth decay, gum disease, and other oral health issues.

The diverse team of healthcare providers caring for a patient with a cleft have an important role to play in supporting that person's oral health and overall well-being. This is why oral health nonprofits FDI World Dental Federation (FDI) and Smile Train have joined forces with support from GSK Consumer Healthcare to launch guidelines for oral health professionals and the wider cleft care team to help reduce oral disease and improve oral health in people born with clefts. Through the release of these new guidelines, FDI and Smile Train hope to empower local cleft teams with training and resources to improve oral health and provide comprehensive oral healthcare. To learn more about the guidelines, providers are encouraged to join the FDI Oral Health Campus webinar on 29 September at 15:00 BST where they will be released for the first time. You can register for the webinar here.

In this webinar, the panel of FDI and Smile Train experts will present the Oral Health in Comprehensive Cleft Care guidelines, discuss the oral health challenges that people with treated or untreated clefts often face, and offer clear solutions to optimize patients' well-being, ensuring that they're able to eat, speak, breathe, and swallow.

Rehabilitation and care of children with clefts often involves the core specialties of nursing, plastic surgery, paediatric dentistry, speech therapy, and orthodontics. All members of this cleft care team can contribute to reinforcing the patient's oral health - ideally, by following a set of agreed and adopted protocols to ensure good interdisciplinary communication.

"Children with clefts suffer disproportionally from oral disease, which can not only affect their overall health and well-being, but also their long-term development," said FDI President Dr Gerhard K. Seeberger. "Ensuring that the cleft care team is trained to help prevent oral disease is so important. FDI is delighted to share these new guidelines, which we hope will empower the whole team to deliver consistent, quality care to all patients living with clefts."

"We aim to integrate oral health into the care pathway for children with clefts," said Smile Train President and CEO Susannah Schaefer. "Regular dental care for children with clefts is essential to help manage their increased risk for oral disease. It's important for healthcare providers and caregivers to recognize the signs of oral diseases and know how to prevent them. This is the only way to enable people with clefts to enjoy the highest possible quality of life."

"At GSK, we understand the importance of good oral health and hygiene for all, especially for those living with clefts," said GSK Global Category Lead Oral Health Jayant Singh. "Comprehensive cleft care is a key focus of the work we support with Smile Train and FDI. We are so excited about the release of these guidelines, which we think will serve as a transformative and indispensable tool for the entire cleft care team."

 Webinar access here







EQUIA® Restorative System: Outstanding Performance Confirmed By Several Long-Term Clinical Trials

Posted on September 21, 2020

Introduced in 2007, the EQUIA® restorative system quickly proved to be a new standard in restorative technology, offering esthetically pleasing bulk-fill posterior restorations and an advanced option to overcome the limitations of amalgam, composite and conventional glass ionomer restoratives. Over the years, EQUIA® has inspired a number of prominent research groups to evaluate its clinical performance in several short- and long-term trials.

Mounting Evidence For EQUIA®

A significant number of articles published in high-ranked journals brought in light the remarkable performance of EQUIA® in Class I and II restorations after two- and three-year follow-up periods (Friedl et al1; Klinke et al2; Olegario et al3; Fatidou et al4; Lopez et al5). Two additional studies (Turkun et al6 and Basso et al7) evaluated EQUIA® restorations after longer periods of six and seven years respectively, concluding about its reliability and durability for Class I, II and V restorations.

Other leading studies compared EQUIA® to conventional resin composites. For instance, Menezes Silva et al8 and Kupietzky et al9 demonstrated that EQUIA® had similar rates of success when compared to a composite resin in Class II restorations after three years.

After a 5-year trial, Molina et al10 revealed EQUIA®’s optimal performance when treating special care patients. EQUIA® also proved to be a trustworthy restorative option for noncarious cervical lesions after one and three years as described by Vaid et al11 and Celik et al12 respectively. A randomized controlled trial leaded by Heck et al13 showed, after a six-year follow-up, the satisfactory performance of EQUIA® to restore two- or three-surface class II restorations.

Finally, Gurgan et al14. conducted a notable 10-year clinical trial reporting an outstanding success rate of 100% for the EQUIA® restorative system in class I and II cavities. Glass Hybrid Materials: A New Era Of Performance Building on the extensive and positive clinical evidence of the EQUIA® restorative system, GC introduced EQUIA Forte®, the first glass hybrid, in 2015, and offering an unprecedented option for long-term restorations.

The interim results of clinical studies show the suitability of EQUIA Forte® as a longterm material to restore extended size Class II cavities.* Gurgan S. et al15 compared EQUIA Forte® to a micro-hybrid composite; concluding that, after four years, both materials presented optimal surface and marginal adaptation characteristics. The EQUIA Forte® multicenter study (Miletic I. et al16) compares the glass-hybrid to a nano-hybrid resin composite (Tetric EvoCeram, Ivoclar Vivadent) and the two-year interim results have shown similar clinical performance for both materials.

Backed by years of extensive research and academically reviewed publications, this literature review provides clinicians with the unwavering confidence in glass hybrid restorative systems as an optimal long-term restorative alternative.

The latest Glass hybrid, EQUIA Forte® HT, offers increased esthetics and strength compared to its predecessor, EQUIA Forte®; confirming that glass-hybrids are a trustworthy long-term restorative option for the dentist, while still being cost effective for patients. For more information, please visit www.gcamerica.com.







Whip Mix to Consolidate 25-, 50-, 55-lb Gypsum Products to 33-lb Packaging

Posted on September 21, 2020

Whip Mix is pleased to announce a change to its gypsum packaging. As a result of surcharges on 50-lb+ packages introduced at the beginning of 2020 by UPS and FedEx, Whip Mix will be changing all 25-, 50-, and 55-lb cartons of our gypsum packaging to 33-lb cartons. They are currently working on phasing in this change-over and expect to start shipping the new size starting in late September.

 







Daniel J. Burke Discusses Pacific Dental Services’® COVID-19 Response

Posted on September 18, 2020

Daniel Burke, Chief Enterprise Strategy Officer at leading dental support organization (DSO) Pacific Dental Services (PDS®) discusses how PDS was able to quickly pivot its service model to help its supported practices during the earlier days of the COVID-19 crisis, including adding teledentistry capability in a new interview on the Becker's Dental + DSO Review Podcast titled, "Teledentistry, the Oral-Systemic Link, and More with Dan Burke." During the podcast, Mr. Burke discusses how PDS enabled its supported owner dentists to stay open to see dental emergencies when nearly all of their peers were forced to close in the middle of the Novel Coronavirus pandemic. For example, PDS was able to launch teledentistry in five days in April, which allowed PDS-supported dentists the ability to increase access to care for anyone with a smart phone, tablet or a computer. For more information on teledentistry, click HERE.

"Teledentistry was a solution looking for a problem, and COVID-19 was that problem," said Mr. Burke. "There was a lot of fear for patients who were at home and wondering if they should go to an emergency room for their dental emergencies. Prior to all PDS-supported practices reopening for general and emergency dentistry, teledentistry served as a great tool for patients to have a live person-to-person conversation with a clinician, and our supported dentists were able to screen patients. It still remains a popular and powerful tool."

Mr. Burke also discusses how the oral-systemic link has impacted the dental industry, and how PDS-supported dental practices were able to support their communities by staying open to treat dental emergencies.

To listen to the Becker's Dental + DSO Review Podcast episode, "Teledentistry, the Oral-Systemic Link, and More with Dan Burke," click HERE. The team at Becker's Dental + DSO Review Podcast interviews a variety of leaders across the dental and DSO space to learn best practices, share challenges, and exchange ideas.

About Pacific Dental Services®

Founded in 1994, Pacific Dental Services (PDS) is one of the country’s leading dental support organizations, providing supported autonomy that enables dentists to concentrate on clinical excellence and the highest levels of cost-effective comprehensive patient care. PDS originated the Private Practice+® model to enable dentists to focus on their passion: serving patients. PDS also pioneered the concept of Modern Dentistry so that dentists are equipped to combine advances in the latest technology with the best operational practices and procedures, highly skilled support staff and a commitment to ongoing training and education. PDS continues to grow, with over 800 supported dental offices across the United States and plans to expand into several new markets. PDS has been on the Inc. 5000 list of the fastest growing private companies in America 14 times. PDS supported dentists aim to be the provider of choice in all the markets they serve and to develop Patients for Life™.

For more information, visit us at http://www.pacificdentalservices.com

Facebook: https://www.facebook.com/PacificDentalServices/

LinkedIn: https://www.linkedin.com/company/293541/life/

Twitter: https://twitter.com/pacificdental

YouTube: https://www.youtube.com/user/PacificDentalTV







© 2020 AEGIS Communications | Privacy Policy